The advanced glycation end products (AGEs) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and neurodegenerative disorder therapeutics conditions. AGEs are formed when proteins or lipids combine with sugars in the body, leading to harmful compounds that contribute to various diseases. The growing awareness of the role AGEs play in aging and disease progression is propelling research and development in this market. Recent advancements include the development of diagnostic tools to measure AGEs and the introduction of therapeutic agents aimed at reducing their accumulation. Companies are also focusing on the creation of dietary supplements and skincare products to mitigate AGE formation. The market benefits from rising healthcare awareness, technological advancements, and a shift towards preventive care. As healthcare systems focus more on managing chronic diseases and aging-related conditions, the AGEs market is poised for continued expansion with innovative solutions catering to diverse consumer needs.
